552 related articles for article (PubMed ID: 15709189)
21. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
[TBL] [Abstract][Full Text] [Related]
22. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer.
Esposito V; Baldi A; Liuzzi G; Tonini G; Vincenzi B; Persichetti P; Santini M; Ambrogi V; Mineo TC; Montesarchio V; Wolner E; Baldi F; Groeger AM
Anticancer Res; 2003; 23(6C):4901-5. PubMed ID: 14981943
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G; Jones JL; O'Byrne KJ
Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
Tanaka F; Otake Y; Yanagihara K; Yamada T; Miyahara R; Kawano Y; Li M; Inui K; Wada H
Br J Cancer; 2001 Jan; 84(2):263-9. PubMed ID: 11161386
[TBL] [Abstract][Full Text] [Related]
29. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
[TBL] [Abstract][Full Text] [Related]
30. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
31. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
[TBL] [Abstract][Full Text] [Related]
32. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Lu C; Soria JC; Tang X; Xu XC; Wang L; Mao L; Lotan R; Kemp B; Bekele BN; Feng L; Hong WK; Khuri FR
J Clin Oncol; 2004 Nov; 22(22):4575-83. PubMed ID: 15542809
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin expression and prognostic significance in non-small cell lung cancer.
Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Wang J; Liu X; Jiang W; Liang L
Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
40. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]